{{Drugbox
| Watchedfields = changed
| verifiedrevid = 470611393
| IUPAC_name = 2-Benzyl-4,5-dihydro-1''H''-imidazole
| image = Tolazoline.svg
| width = 150

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|tolazoline}}
| pregnancy_category =  
| legal_status =  
| routes_of_administration = [[Intravenous therapy|IV]]

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =

<!--Identifiers-->
| IUPHAR_ligand = 7310
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 59-98-3
| ATC_prefix = C04
| ATC_suffix = AB02
| ATC_supplemental =  {{ATC|M02|AX02}} {{ATCvet|V03|AB94}}
| PubChem = 5504
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00797
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5303
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = CHH9H12AQ3
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08614
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 28502
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 770

<!--Chemical data-->
| C=10 | H=12 | N=2
| molecular_weight = 160.216 g/mol
| smiles = N\1=C(\NCC/1)Cc2ccccc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H12N2/c1-2-4-9(5-3-1)8-10-11-6-7-12-10/h1-5H,6-8H2,(H,11,12)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = JIVZKJJQOZQXQB-UHFFFAOYSA-N
}}

{{other use|Adrenergics}}

'''Tolazoline''' is a non-selective [[Competitive antagonist|competitive]] α-[[adrenergic receptor]] [[Receptor antagonist|antagonist]]. It is a [[vasodilator]] that is used to treat spasms of peripheral blood vessels (as in [[acrocyanosis]]). It has also been used (in conjunction with sodium nitroprusside) successfully as an antidote to reverse the severe [[peripheral vasoconstriction]] which can occur as a result of [[overdose]] with certain [[5-HT2A receptor|5-HT<sub>2A</sub>]] [[agonist]] drugs such as [[25I-NBOMe]],{{citation needed|date=July 2014}} [[2,5-Dimethoxy-4-bromoamphetamine|DOB]] and [[Bromodragonfly]] (prolonged severe vasoconstriction can lead to [[gangrene]] if untreated).<ref>Bowen JS, Davis GB, Kearney TE, Bardin J. Diffuse vascular spasm associated with 4-bromo-2,5-dimethoxyamphetamine ingestion. ''Journal of the American Medical Association'' 1983 Mar 18;249(11):1477-9. {{PMID|6827726}}</ref><ref>Thorlacius K, Borna C, Personne M. Bromo-dragon fly--life-threatening drug. Can cause tissue necrosis as demonstrated by the first described case. (Swedish) ''Lakartidningen''. 2008 Apr 16-22;105(16):1199-200. {{PMID|18522262}}</ref>

It is however most commonly used in [[veterinary medicine]], to reverse [[xylazine]]-induced [[sedation]].<ref>{{cite book |author=Boothe DM |chapter=Anticonvulsant drugs and analeptic agents |title=Veterinary pharmacology and therapeutics |editor=Adams HR |publisher=Iowa State University Press |location=Ames |year=2001 |pages=378–9 |isbn=0-8138-1743-9 |url=https://books.google.com/books?id=2CUbc0RXvb8C}} Retrieved September 8, 2008 through [[Google Book Search]].</ref><ref>{{cite book |vauthors=Hall LW, Clarke KW, Trim CM |chapter=Principles of sedation, analgesia and premedication |title=Veterinary anaesthesia |publisher=W.B. Saunders |location=Philadelphia |year=2001 |pages=90–1 |isbn=0-7020-2035-4 |url=}} Retrieved September 8, 2008 through [[Google Book Search]].</ref>

==References==
{{Reflist}}

{{Adrenergics}}
{{Peripheral vasodilators}}
{{Topical products for joint and muscular pain}}

[[Category:Disulfiram-like drugs]]
[[Category:Imidazolines]]
[[Category:Vasodilators]]
[[Category:Veterinary drugs]]